Frémeaux-Bacchi V - Search Results

1

Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes.

Fischer EM, Mouhoub A, Maillet F, Frémeaux-Bacchi V, Krief C, Gould H, Berrih-Aknin S, Kazatchkine MD. Fischer EM, et al. Int Immunol. 1999 Nov;11(11):1841-9. doi: 10.1093/intimm/11.11.1841. Int Immunol. 1999. PMID: 10545488

2

Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.

Frémeaux-Bacchi V, Bernard I, Maillet F, Mani JC, Fontaine M, Bonnefoy JY, Kazatchkine MD, Fischer E. Frémeaux-Bacchi V, et al. Eur J Immunol. 1996 Jul;26(7):1497-503. doi: 10.1002/eji.1830260714. Eur J Immunol. 1996. PMID: 8766552

3

Membrane and soluble forms of CD21 (the C3dg/EBV receptor).

Frémeaux-Bacchi V, Fischer E, Kazatchkine MD. Frémeaux-Bacchi V, et al. Immunol Lett. 1996 Dec;54(2-3):201-4. doi: 10.1016/s0165-2478(96)02673-9. Immunol Lett. 1996. PMID: 9052878 Review. No abstract available.

4

Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.

Frémeaux-Bacchi V, Fischer E, Lecoanet-Henchoz S, Mani JC, Bonnefoy JY, Kazatchkine MD. Frémeaux-Bacchi V, et al. Int Immunol. 1998 Oct;10(10):1459-66. doi: 10.1093/intimm/10.10.1459. Int Immunol. 1998. PMID: 9796912

5

Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23.

Frémeaux-Bacchi V, Aubry JP, Bonnefoy JY, Kazatchkine MD, Kolb JP, Fischer EM. Frémeaux-Bacchi V, et al. Eur J Immunol. 1998 Dec;28(12):4268-74. doi: 10.1002/(SICI)1521-4141(199812)28:12<4268::AID-IMMU4268>3.0.CO;2-9. Eur J Immunol. 1998. PMID: 9862364 Free article.

6

Functional properties of soluble CD21.

Frémeaux-Bacchi V, Kolb JP, Rakotobé S, Kazatchkine MD, Fischer EM. Frémeaux-Bacchi V, et al. Immunopharmacology. 1999 May;42(1-3):31-7. doi: 10.1016/s0162-3109(99)00026-0. Immunopharmacology. 1999. PMID: 10408363 Review.

7

Assessment of complement activation in clinical samples. Comparison of immunochemical and functional measurements of complement components with quantitation of activation fragments.

Maillet F, Frémeaux-Bacchi V, Uhring-Lambert B, Kazatchkine MD. Maillet F, et al. J Immunol Methods. 1992 Dec 8;156(2):171-8. doi: 10.1016/0022-1759(92)90023-m. J Immunol Methods. 1992. PMID: 1474254

8

Complete inherited deficiency of the fourth complement component in a child with systemic lupus erythematosus and his disease-free brother in a north African family.

Fremeaux-Bacchi V, Uring-Lambert B, Weiss L, Brun P, Blouin J, Hartmann D, Loirat C, Hauptmann G, Kazatchkine MD. Fremeaux-Bacchi V, et al. J Clin Immunol. 1994 Sep;14(5):273-9. doi: 10.1007/BF01540980. J Clin Immunol. 1994. PMID: 7814456

9

Restricted genetic defects underlie human complement C6 deficiency.

Dragon-Durey MA, Fremeaux-Bacchi V, Blouin J, Barraud D, Fridman WH, Kazatchkine MD. Dragon-Durey MA, et al. Clin Exp Immunol. 2003 Apr;132(1):87-91. doi: 10.1046/j.1365-2249.2003.02099.x. Clin Exp Immunol. 2003. PMID: 12653841 Free PMC article.

10

Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.

Frémeaux-Bacchi V, Weiss L, Brun P, Kazatchkine MD. Frémeaux-Bacchi V, et al. Nephrol Dial Transplant. 1994;9(7):811-4. Nephrol Dial Transplant. 1994. PMID: 7970124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters